[go: up one dir, main page]

AU2001281950A1 - Regulation of human thimet oligopeptidase-like enzyme - Google Patents

Regulation of human thimet oligopeptidase-like enzyme

Info

Publication number
AU2001281950A1
AU2001281950A1 AU2001281950A AU8195001A AU2001281950A1 AU 2001281950 A1 AU2001281950 A1 AU 2001281950A1 AU 2001281950 A AU2001281950 A AU 2001281950A AU 8195001 A AU8195001 A AU 8195001A AU 2001281950 A1 AU2001281950 A1 AU 2001281950A1
Authority
AU
Australia
Prior art keywords
enzyme
regulation
thimet oligopeptidase
human
human thimet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001281950A
Other languages
English (en)
Inventor
Shyam Ramakrishnan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2001281950A1 publication Critical patent/AU2001281950A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2001281950A 2000-07-05 2001-07-04 Regulation of human thimet oligopeptidase-like enzyme Abandoned AU2001281950A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21635400P 2000-07-05 2000-07-05
US60/216,354 2000-07-05
PCT/EP2001/007634 WO2002002755A2 (fr) 2000-07-05 2001-07-04 Regulation d'enzyme de type thimet oligopeptidase humaine

Publications (1)

Publication Number Publication Date
AU2001281950A1 true AU2001281950A1 (en) 2002-01-14

Family

ID=22806716

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001281950A Abandoned AU2001281950A1 (en) 2000-07-05 2001-07-04 Regulation of human thimet oligopeptidase-like enzyme

Country Status (2)

Country Link
AU (1) AU2001281950A1 (fr)
WO (1) WO2002002755A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US9414777B2 (en) 2004-07-13 2016-08-16 Dexcom, Inc. Transcutaneous analyte sensor
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US20110024043A1 (en) 2009-07-02 2011-02-03 Dexcom, Inc. Continuous analyte sensors and methods of making same
WO2011041463A2 (fr) 2009-09-30 2011-04-07 Dexcom, Inc. Capteur d'analyte transcutané

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292652A (en) * 1990-10-05 1994-03-08 Athena Neurosciences, Inc. Amyloidin protease and uses thereof
EP0789758A2 (fr) * 1995-09-05 1997-08-20 Celltech Therapeutics Limited Codage de sequences d'adn destine a une metalloproteinase humaine et ses variants

Also Published As

Publication number Publication date
WO2002002755A3 (fr) 2002-08-22
WO2002002755A2 (fr) 2002-01-10

Similar Documents

Publication Publication Date Title
AU2002231206A1 (en) Treatment of depression
AU2001269123A1 (en) Regulation of human dipeptidyl-peptidase iv-like enzyme
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001284380A1 (en) Therapeutic and cosmetic uses of heparanases
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2002223522A1 (en) Regulation of human pyroglutamyl peptidase-like enzyme
AU2001281969A1 (en) Regulation of human carboxylesterase-like enzyme
AU2001285782A1 (en) Regulation of human phosphodiesterase-like enzyme
AU2002210525A1 (en) Regulation of human phospholipase-like enzyme
AU2002215942A1 (en) Regulation of human carboxylesterase-like enzyme
AU2001281939A1 (en) Regulation of human alpha-hydroxysteroid dehydrogenase-like enzyme
AU2001295602A1 (en) Regulation of human phospholipase a2-like enzyme
AU2001269095A1 (en) Regulation of human caspase-1-like protease
AU2002219046A1 (en) Regulation of human ceruloplasmin-like protein
AU2002215956A1 (en) Regulation of human pgc-1-like protein
AU2002231620A1 (en) Regulation of human patched-like protein
AU5033101A (en) Regulation of human heparanase-like enzyme
AU2002212246A1 (en) Regulation of human serine palmitoyltransferase-like enzyme
AU2001256350A1 (en) Regulation of human lysostaphin-like protease
AU2002221781A1 (en) Regulation of human inositolpolyphosphate 5-phosphatase
AU2002237225A1 (en) Regulation of human patched-like protein
AU2002212318A1 (en) Regulation of human phospholipase a2-like enzyme
AU2001293830A1 (en) Regulation of human aminotransferase-like enzyme
AU2002210464A1 (en) Regulation of human aminotransferase-like enzyme